More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$348950908
EPS
0.47
P/E ratio
40.5
Price to sales
0.38
Dividend yield
--
Beta
0.763754
Previous close
$18.88
Today's open
$18.96
Day's range
$18.84 - $19.27
52 week range
$16.60 - $38.32
show more
CEO
Kevin Guest
Employees
1700
Headquarters
Salt Lake City, UT
Exchange
New York Stock Exchange
Shares outstanding
18463011
Issue type
Common Stock
Consumer Staples
Consumer Products - Healthcare
USANA Health Sciences: How The Restructuring Plan Makes It A Strong Buy
USANA Health Sciences is undergoing restructuring, causing temporary margin pressure but positioning for significant future profit expansion. Rise Wellness posted 740% revenue growth, but gross margin fell to 7.1% due to promotional discounts; margin recovery is expected as restocking begins at regular prices. Hiya's revenue dropped 13.3% amid higher CAC from Meta algorithm changes; in-house manufacturing should drive cost savings in H2.
Seeking Alpha • Jun 19, 2026

USANA Celebrates 10 Years of Making the World a Better Place During World Service Week
SALT LAKE CITY, June 16, 2026 /PRNewswire/ -- For the past 10 years, the USANA community comes together every June through acts of service during World Service Week led by the USANA Foundation. World Service Week unites the USANA family across continents for a week of service and compassion.
PRNewsWire • Jun 16, 2026

5 Low Price-to-Book Stocks That Are Worth Buying in June
STNE, USNA, STRA, NEXA and CVS passed a low price-to-book screen, combining discounted valuations with projected long-term EPS growth.
Zacks Investment Research • Jun 12, 2026

These 4 Low Price-to-Cash Flow Stocks Have Winning Potential
Nexa Resources leads a screen of four low P/CF value stocks, with consensus sales and EPS growth forecasts and wildly mixed 12-month returns.
Zacks Investment Research • Jun 11, 2026

Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Jun 10, 2026

USANA Earns Dual Best of State Honors for Product Innovation and Development
USANA's CellSentials and Research and Development team honored at the awards SALT LAKE CITY, June 4, 2026 /PRNewswire/ -- USANA, a leader in global nutrition, earned two Best of State awards in Salt Lake City, Utah, recognizing its CellSentials supplements and Research and Development team. USANA took home two Best of State medals this year in the following categories: Dietary Supplement—USANA CellSentials took home this honor for the tenth consecutive year Research and Development—USANA's R&D team won for the eighth time To learn more about USANA and its award-winning products, please visit USANA.com.
PRNewsWire • Jun 4, 2026

Kevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness Month
USANA CEO says small daily habits can strengthen health, improve workplace culture, and help others thrive SALT LAKE CITY, June 1, 2026 /PRNewswire/ -- As Professional Wellness Month begins in June, Kevin Guest, Chairman and CEO of USANA Health Sciences (NYSE: USNA), is encouraging professionals, leaders, and organizations to make wellness a priority both at work and at home. He says healthier habits create stronger people, stronger teams, and stronger communities.
PRNewsWire • Jun 1, 2026

Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • May 25, 2026

4 Top Value Stocks to Buy Now as Wall Street Takes Fresh Notice
Four low P/CF value picks, Nexa Resources, Avnet, Strategic Education and USANA Health, screened for discount valuations and strong trading volume.
Zacks Investment Research • May 22, 2026

USNA or SDZNY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research • May 12, 2026

¹ Disclosures

Open an M1 investment account to buy and sell USANA Health Sciences Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.